In the Department of Cardiology, we maintain a heavy academic interest in improving the lives of our patients through careful research and scientific study.
We offer a range of diagnostic tests and treatments that are not offered anywhere else, and focus on ensuring that patients are offered the utmost in advances in recent evidence based medicine. The Alfred co-ordinates several large international research trials while also running focused tailored trials for patients, offering close clinical contact and access to cutting edge research.
We have a number of collaborative studies with Baker Heart & Diabetes Institute, the Burnet Institute and other Alfred Health departments including Gastroenterology, Rheumatology, Infectious Diseases, Cardiothoracic Surgery and Intensive Care. Several distinguished members of the department have published in the key academic journals in cardiology, from the American Heart Association, American College of Cardiology and European Society of Cardiology.
We firmly believe in patient centred care, and offering the latest that research has to offer is part of that.
Heart failure research
Professor David Kaye and his colleagues in the Heart Failure and Transplant service undertook a series of studies to investigate the causes and to develop new treatments for patients with heart failure.Find out more
The electrophysiology service, headed by Professor Peter Kistler, has a particular interest in the relationship between atrial fibrillation and heart failure.Find out more
Cardiac imaging research
Professor Taylor’s group was the first in the world to utilize cardiac magnetic resonance (CMR) T1 mapping techniques to quantify diffuse myocardial fibrosis in humans, where it is associated with heart failure severity.Find out more
Structural Heart research
The Structural Heart Program commenced in 1995, when the team were pioneers in Australia, being the first to provide Transcatheter Aortic Valve Implantation (TAVI) in Victoria in 2008. TAVIs are provided to high risk patients with severe aortic stenosis. This program continues to be one of the largest in Australia.Find out more
Those of us who have been treating patients with high cholesterol levels, in some of whom this was genetic (Familial Hypercholesterolaemia or FH), were frustrated “in the old days” by absence of a powerful cholesterol lowering drug.Find out more
Many patients with high blood pressure try to follow a healthy diet, exercise, and take medications — yet their blood pressure is still high.Find out more
Acute coronary syndromes research
Dr James Shaw is currently the Director of Education and Training in the Cardiology department. Whilst being an interventional Cardiologist Dr Shaw has participated in numerous research projects. Major areas of interest include: hyperlipidaemia.Find out more
Is early rehabilitation a myth? Physical inactivity in the first week after myocardial infarction and stroke
Lay S, Bernhardt J, West T, Churilov L, Dart A, Hayes K, Cumming TB
(2016), Disabil Rehabil, 38(15),
Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction
Yudi MB, Ramchand J, Farouque O, Andrianopoulos N, Chan W, Duffy SJ, Lefkovits J, Brennan A, Spencer R, Fernando D, Hiew C, Freeman M, Reid CM, Ajani AE, Clark DJ; Melbourne Interventional Group
(2016), Int J Cardiol, 224,
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE; Melbourne Interventional Group
(2016), Intern Med J, 46(5),